课题基金 / 基金详情

Chemokine Network and HIV Pathogenesis: New Insights into the Functional Heterogeneity of Monocyte-Derived Dendritic Cells and CD4+ T-Cells

Chemokine Network and HIV Pathogenesis: New Insights into the Functional Heterogeneity of Monocyte-Derived Dendritic Cells and CD4+ T-Cells
趋化因子网络和 HIV 发病机制：对单核细胞衍生的树突状细胞和 CD4 T 细胞功能异质性的新见解
批准号：
199383
负责人：
Ancuta Petronela
金额：
$7.29万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-09-01 至 2010-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=199383&lang=en
关键词：
Chemokines/Chemokine Receptors And Inflammation Dendritic Cells And Cd4+ T Cells Facs Sorting And Confocal Microscopy Hiv And Viral Reservoirs Immune And Virological Synapse Real Time Pcr And High Throughput Chemokine Screening

项目摘要

项目成果

Ancuta Petronela的其他基金

相关文献

中文摘要
翻译
我们的假设是，单核细胞来源的树突状细胞(MDDC)和CD4+T细胞的离散亚群对抗HIV免疫和病毒复制/持续有不同的贡献，而特定的趋化因子和趋化因子受体
英文摘要
Our hypothesis is that discrete uncharacterized subsets of monocyte-derived dendritic cells (MDDC) and CD4+ T-cells differentially contribute to anti-HIV immunity and viral replication/persistence and that specific chemokines and chemokine receptors gover
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding the Perfect Time to Hunt for HIV: A Tale of 36 Hours at the CHUM
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy